Immunoassay Market Size To Expand at a Notable CAGR Of 8.5% During 2017 - 2023

Pune, India, February,2019/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Immunoassay Market

Overview:

The global immunoassay market, as reported in the latest study of the market by Market Research Future (MRFR), is expecting a growth by 8.5% CAGR during the forecast period (2017-2023). A substantial market valuation will be achieved by the end of 2023 by the market if this remains the growth rate of the market in the coming years. Immunoassay uses a small antibody or an antigen to determine the presence of a small molecule in a solution. The detected molecule is called an analyte, and it happens to be protein in many cases. Mostly collected from serums or urine, these analytes are analyzed for the various medical and research purposes. Often the process requires a calibrator for a better analysis. Immunoassays find much traction in the healthcare sector for their ability to find results rapidly and accuracy. MRFR in their recent report on the immunoassay market included several market factors for a holistic understanding of the global market. The report also has its focus on segmental analysis that includes detailed volume-wise and value-wise analysis.

Growing biotechnology and pharmaceutical sectors, across the globe, is all set to provide stimulants for the market growth. Oncology department is also gaining much benefits from its use and concerns regarding the prevalence of cancer can be considered a serious factor. Government initiatives and supportive regulatory framework can also be considered of significant importance. But the complex procedure of the test and lack of specificity in the results can be a market deterrent. 

Segmentation:

MRFR segments the global immunoassay market by product and service, type, and end-user.

Based on the product and service, the immunoassay market can be segmented into reagents and kits, analyzers, and software and services. The reagents and kits segment includes Enzyme-Linked Immunosorbent Assay (ELISA) reagents & kits, elispot reagents & kits, western blot reagents & kits, rapid test reagents & kits, RIA reagents & kits, and PCR reagents & kits. The analyzers segment can be segmented into portable analyzers and benchtop analyzers.

Based on the type, the immunoassay market can be segmented into Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Radioimmunoassay (RIA), Fluoroimmunoassay (FIA), Counting Immunoassay (CIA), and Chemiluminescence immunoassay (CLIA).

Based on the application, the immunoassay market can be segmented into infectious diseases, autoimmune disorders, oncology, neonatal screening, toxicology, hematology & blood screening, cardiology, bone & mineral disorders, and others.

Based on the end-user, the immunoassay market includes biotechnology companies, diagnostic laboratories, research & academic laboratories, hospitals & clinics, pharmaceutical companies, and others.Browse Complete Report @ https://www.marketresearchfuture.com/reports/immunoassay-market-5841

Regional Analysis

MRFR segments regionally the immunoassay market for their report based on the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Parasitic diseases and infectious diseases are one of the major tractions that are assisting the Americas’ immunoassay market in its expansion. Healthcare sector is including the testing technique as a part of their regular diagnosis strategy to make the treatment more efficient and effective. This widespread inclusion of the technology is guaranteeing the regional market’s prospect.

Europe is set to experience high growth during the forecast period owing to initiatives taken by governments and private investors to provide a substantial market scope for growth. Technological brilliance and presence of major market players can also be considered pivotal factors.

The APAC market’s emergence as a better destination for market expansion strategies is playing well for the regional market. The regional healthcare development in India, China, Singapore, and other countries are creating many opportunities for the market to develop new strategies. 

Competitive Landscape:

Major players, as reported by MRFR in the global immunoassay treatment market are Abbott Laboratories, Beckman Coulter, Inc., Alere, Arlington Scientific, Radiometer, Bio-Rad Laboratories, BioMerieux, Inc., DiaSorin, Diamedix, Fujirebio US, Dynex Technologies, Gold Standard Diagnostics, Hycor Biomedical, Inova Diagnostics, Randox Toxicology, Ortho-Clinical Diagnostics, F. Hoffmann-La Roche Ltd., ThermoFisher Scientific, Siemens Healthineers, Wako Diagnostics, TOSOH Bioscience, Shenzhen New Industries Biomedical Engineering Co., Ltd., Sysmex Corporation, and others. 

In 2018, researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Brigham and Women's Hospital (BWH) developed a new method that can detect small molecules with 50 times greater sensitivity. The process includes a competitive immunoassay technique to find better results.